“…A large number (>150) of single-point mutations and chimeras of human TRPA1 have been functionally characterized in the literature (Meents et al, 2019), yet the published data do not enable us to fully understand the molecular details of the channel function, mostly because (1) the available structures of TRPA1 capture the channel in an intermediate or inactivated conformation (Paulsen et al, 2015;Suo et al, 2020) which does not allow to distinguish the functional states, (2) the structures lack information on a considerable (∼50%) part of the protein, (3) the impact of the interactions of TRPA1 with various important endogenous proteins and cellular signaling mechanisms has not yet been fully characterized (Zygmunt and Hogestatt, 2014;Gouin et al, 2017;Talavera et al, 2019), and (4) the extent to which TRPA1 can be regulated by its membrane environment is still only gradually being uncovered (Hirono et al, 2004;Akopian et al, 2007;Dai et al, 2007;Karashima et al, 2008;Witschas et al, 2015;Macikova et al, 2019;Startek et al, 2019). Obviously, a better understanding of all these issues is key for a precise description of the mechanisms of TRPA1 activation, and, perhaps more importantly, for rational screening of its novel modulators as potential therapeutic agents.…”